|
FY2026
12 months to Jun 30, 2026
|
FY2025
12 months to Jun 30, 2025
|
|
|---|---|---|
| Net loss | ||
| Adjustments to reconcile net loss to net cash used in operating activities | ||
| Changes in operating liabilities: | ||
| IPO costs written off | ||
| (Increase)/decrease in account receivable | ||
| Increase/(decrease) in Accounts Payable | ||
| Net cash used in operating activities | ||
| Proceeds from issuance of ordinary shares | ||
| Payment of IPO costs | ||
| Net cash used in investing activities | ||
| Amount due to a Director | ||
| Net cash provided by / (used from) financing activities | ||
| Net change in cash | ||
| Cash at the beginning of the year | ||
| Cash at the end of the year |
Loading...
